Dr. Mhaka is a Lifesciences and digital health strategist, investment professional, entrepreneur and executive who has a passion for blending emerging technologies, business, and science to support health and well-being of the global community. She has incorporated into Mawambo her expansive knowledge of Nanotechnology, Nanoelectronics, Data as a Centralized Platform, and Artificial Intelligence (AI) with her expertise and network in biomedical discovery, research & technology development, healthcare delivery and fundraising to further her mission of accelerating global healthcare solutions.
Utilizing her experience in cross-disciplinary and multi-stakeholder approaches, Annastasiah co-founded the Alliance for Artificial Intelligence in Healthcare (AAIH), a global coalition of 30+ organizations dedicated to resolving the myriad challenges facing the growing field of AI- and Machine Learning-based life sciences and healthcare solutions. In addition to her proven track record of over 50+ cross-industry deals in both the private and public sectors, Annastasiah worked for a leading management consultant firm and co-founded five companies ($70M+ in Series A) within the drug development and nanotechnology sectors. This includes a mid-stage AI-supported nanotechnology platform for diagnostics, disease management, therapeutic monitoring, data processing, and transmission at the point-of-need.
Annastasiah received her PhD in Cellular and Molecular Medicine from Johns Hopkins Medicine where she developed a clinical phase oncology drug, and attained her Bachelor of Science in Chemistry [Highest Honors, Summa Cum Laude] from the University of Pittsburgh.
See more at www.mawambo.com.
Focus Areas: Immunology & Inflammation, Oncology, Infectious Diseases, Neurology, Gastroenterology, Metabolic Disorders, Cardiology, Dermatology, Orphan and Neglected Diseases, Surgery and Critical Care, Ambulatory Care, Home Health, In-patient care, Intensive and Critical Care (ICU), Pathology, Radiation Oncology, Radiology, Urgent Care.